Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

2001 • 2,749 citations

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

2002 • 2,056 citations

The Biology of Chronic Myeloid Leukemia

1999 • 1,308 citations

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

2002 • 1,195 citations

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

2002 • 1,069 citations

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

2002 • 566 citations

Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy

1995 • 446 citations

Imatinib mesylate (STI571) therapy for Philadelphia chromosome–positive chronic myelogenous leukemia in blast phase

2002 • 307 citations

Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival

1985 • 214 citations

Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia

1990 • 209 citations

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

2003 • 129 citations

Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia

2004 • 104 citations

Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome‐positive chronic myelogenous leukemia

2003 • 92 citations

Molecular response to imatinib in late chronic-phase chronic myeloid leukemia

2003 • 86 citations

Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.

2003 • 45 citations

Comparison Between Patients With Philadelphia-Positive Chronic Phase Chronic Myeloid Leukemia Who Obtained a Complete Cytogenetic Response Within 1 Year of Imatinib Therapy and Those Who Achieved Such a Response After 12 Months of Treatment

2006 • 44 citations

Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients.

2003 • 42 citations

Results of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older

1996 • 42 citations

Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment.

2006 • 42 citations

Successful Medical Management of Neutropenic Enterocolitis in Adults With Acute Leukemia

1987 • 34 citations

Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients

2006 • 26 citations

Old Age

1987 • 18 citations

Interferon-α for the treatment of elderly patients with chronic myeloid leukaemia

1998 • 17 citations

Progress with interferon in CML--results of the MRC UK CML III study.

1996 • 16 citations

Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival

1985 • 14 citations